Integrated Annual Report 2025

4 Segment information

Accounting policy

dsm-firmenich has segmented its operations by business activity from which revenues are earned and expenses incurred. These operating results are regularly reviewed by the Executive Committee, dsm-firmenich’s Chief Operating Decision Maker (CODM), to make decisions about resources to be allocated to the operating segments and assess their performance. dsm-firmenich uses Adjusted EBITDA as the main indicator to evaluate the consolidated performance as well as the performance per operating segment. Discrete financial information is available for each identified operating segment.

The same accounting policies applied to the Consolidated Financial Statements of dsm-firmenich are also applied to the operating segments. Prices for transactions between segments are determined on an arm’s length basis at market-based prices. Segment results, assets and liabilities include items directly attributable to a segment as well as those that can reasonably and consistently be allocated. Interest income, interest expense, and income tax expense or income are not allocated to segments as these amounts are not included in the measure of segment profit or loss reviewed by the Executive Committee, or otherwise regularly provided to the Executive Committee. Selected information on a country and regional basis is provided in addition to the information about operating segments.

Operating segments

The continuing operations of dsm-firmenich are organized into three distinct Business Units:

  • Perfumery & Beauty (P&B) creates premium scents with proven benefits, using the best and largest palette of natural, synthetic, and biotech ingredients. P&B excludes the Aroma Ingredients business, which was transferred to Animal Nutrition & Health (ANH) in view of the carve-out.

  • Taste, Texture & Health (TTH) helps customers create food and beverage products that are delicious, nutritious, affordable, and sustainable – providing enjoyment and nourishment for consumers, and better health for People and Planet. TTH includes the Bovaer® business, which was transferred from ANH in view of the carve-out.

  • Health, Nutrition & Care (HNC) provides people a way to look after their health by adding critical nutrients to their diets, driving medical innovation forward, speeding up recovery, and enhancing quality of life. HNC includes the Veramaris business, which was transferred from ANH in view of the carve-out.

The ANH business also continued to be a reportable segment throughout 2025; however, in view of its highly probable sale, it was reclassified to ‘discontinued operations’ at year-end 2025.

The Business Units are created with clear end-market orientation and large addressable markets. They are clustered in coherent product and market combinations with similar customers and distribution channels, and their operating results are regularly reviewed by the Executive Committee. Therefore, these Business Units have been identified as the reportable operating segments of dsm-firmenich.

Any consolidated activities outside the three reportable operating segments above are reported as the reportable segment ‘Corporate Activities’. These consist of corporate operating and service activities that are not further allocated to the operating segments.

Following the changes in the composition of the reportable operating segments in view of the carve-out, the previously reported information has been restated accordingly.

dsm-firmenich does not have a single external customer that represents 10% or more of total sales.

Reportable segments

 

 

Perfumery & Beauty

 

Taste,
Texture &
Health

 

Health, Nutrition & Care

 

Corporate Activities

 

Total continuing operations

 

Discontinued operations

 

Total
Group

2025

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

3,760

 

3,146

 

2,102

 

26

 

9,034

 

3,487

 

12,521

Adjusted EBITDA1

 

815

 

648

 

407

 

(98)

 

1,772

 

507

 

2,279

EBITDA

 

807

 

674

 

369

 

(193)

 

1,657

 

588

 

2,245

Adjusted operating profit1

 

460

 

322

 

213

 

(134)

 

861

 

253

 

1,114

Operating profit

 

432

 

340

 

168

 

(229)

 

711

 

(1,588)

 

(877)

Capital expenditures

 

170

 

315

 

123

 

 

608

 

156

 

764

Adjusted EBITDA margin (in %)

 

21.7

 

20.6

 

19.4

 

 

19.6

 

14.5

 

18.2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

20242

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

3,776

 

3,109

 

2,117

 

52

 

9,054

 

3,745

 

12,799

Adjusted EBITDA1

 

842

 

626

 

377

 

(94)

 

1,751

 

367

 

2,118

EBITDA

 

837

 

589

 

357

 

(211)

 

1,572

 

419

 

1,991

Adjusted operating profit1

 

470

 

302

 

199

 

(155)

 

816

 

110

 

926

Operating profit

 

465

 

264

 

92

 

(274)

 

547

 

14

 

561

Capital expenditures

 

182

 

300

 

138

 

 

620

 

144

 

764

Adjusted EBITDA margin (in %)

 

22.3

 

20.1

 

17.8

 

 

19.3

 

9.8

 

16.5

1

See Note 2 Alternative performance measures for the reconciliation to IFRS performance measures.

2

Restated for comparison purposes.

Geographical information

 

 

Switzer­land

 

Nether­lands

 

Rest of EMEA

 

North America

 

Latin America

 

China

 

Rest of Asia

 

Total

2025

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales continuing operations (by destination)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

In € millions

 

214

 

302

 

3,098

 

2,353

 

857

 

671

 

1,539

 

9,034

In %

 

2

 

3

 

35

 

26

 

10

 

7

 

17

 

100

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Workforce at period-end (headcount)1

 

3,678

 

1,763

 

8,437

 

4,204

 

3,577

 

3,324

 

3,567

 

28,550

Intangible assets and property, plant and equipment at year-end (carrying amount)

 

11,190

 

1,555

 

3,279

 

2,393

 

322

 

522

 

297

 

19,558

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2024

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales continuing operations (by destination)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

In € millions

 

173

 

296

 

3,018

 

2,456

 

882

 

708

 

1,521

 

9,054

In %

 

2

 

3

 

33

 

27

 

10

 

8

 

17

 

100

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Workforce at year-end (headcount)1

 

3,734

 

1,776

 

8,134

 

4,155

 

3,565

 

3,365

 

3,485

 

28,214

Intangible assets and property, plant and equipment at year-end (carrying amount)1

 

14,946

 

1,618

 

3,220

 

2,689

 

428

 

603

 

299

 

23,803

1

Refers to Total Group, including discontinued operations

Topic filter

Results